REVIEW ARTICLE
Figure from article: Pitfalls in the diagnosis...
 
KEYWORDS
TOPICS
ABSTRACT
The diagnosis and differential diagnosis of benign, intermediate and malignant melanocytic neoplasms remain a recurring and clinically important challenge in dermatopathology. The difficulty is not limited to rare melanoma variants, it also includes non-melanocytic lesions that simulate melanocytic tumours, benign melanocytic proliferations with worrisome architectural or cytological features, and malignant melanomas with deceptively bland morphology. In such settings, immunohistochemistry is not a substitute for careful histopathological assessment, but it may provide decisive ancillary information when applied as a targeted panel and interpreted in the appropriate morphological and clinical context. This review summarises selected diagnostic pitfalls in melanocytic pathology and highlights the contribution, limitations and practical value of established and newer immunohistochemical markers.
REFERENCES (15)
1.
Busam KJ, Rosai J, Iversen K, Jungbluth AA. Xanthogranulomas with inconspicuous foam cells and giant cells mimicking malignant melanoma: a clinical, histologic, and immunohistochemical study of three cases. Am J Surg Pathol 2000; 24: 864-869.
 
2.
Carlson JA, Healy K, Slominski A, Mihm MC Jr. Melanocytic matricoma: a report of two cases of a new entity. Am J Dermatopathol 1999; 21: 344-349.
 
3.
Zembowicz A, Carney A, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 2004; 28: 31-40.
 
4.
Zembowicz A, Knoepp SM, Bei T, Stergiopoulos S, Eng C, Mihm MC, et al. Loss of expression of protein kinase A regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 2007; 31: 1764-1775.
 
5.
Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, et al. A distinct subset of Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 2012; 36: 818-830.
 
6.
Schmoeckel C, Castro CE, Braun-Falco O. Nevoid malignant melanoma. Arch Dermatol Res 1985; 277: 362-369.
 
7.
Kutzner H, Metzler G, Argenyi Z, Requena L, Palmedo G, Mentzel T, et al. Histological and genetic evidence for a variant of superficial spreading melanoma composed predominantly of large nests. Mod Pathol 2012; 25: 838-845.
 
8.
Lenders D, Aebischer V, Gassenmaier M, Hahn M, Metzler G, Forchhammer S. Nested melanoma and superficial spreading melanoma with prominent nests: a retrospective study on clinical characteristics and PRAME expression. Diagnostics (Basel) 2025; 15: 2279.
 
9.
Hantschke M, Mentzel T, Rutten A, Palmedo G, Calonje E, Lazar AJ, et al. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol 2010; 34: 216-222.
 
10.
Hanna J, Ko JS, Billings SD, Boivin F, Beaudoux O, Pissaloux D, et al. Cutaneous melanocytic tumor with CRTC1:: TRIM11 translocation: an emerging entity analyzed in a series of 41 cases. Am J Surg Pathol 2022; 46: 1457-1466.
 
11.
Lezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ. PRAME expression in melanocytic tumors. Am J Surg Pathol 2018; 42: 1456-1465.
 
12.
Uguen A, Talagas M, Costa S, Duigou S, Bouvier S, De Braekeleer M, et al. A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma. Diagn Pathol 2015; 10: 195.
 
13.
Rodić N, Zampella J, Sharma R, Burns KH, Taube JM. Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations. J Cutan Pathol 2015; 42: 807-814.
 
14.
Lezcano C, Pulitzer M, Moy AP, Hollmann TJ, Jungbluth AA, Busam KJ. Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma. Am J Surg Pathol 2020; 44: 503-508.
 
15.
De la Fouchardière A, Tirode F, Castillo C, Pissaloux D, et al. Attempting to solve the pigmented epithelioid melanocytoma conundrum: PRKAR1A inactivation can occur in different genetic backgrounds. Am J Surg Pathol 2022; 46: 1106-1115.
 
eISSN:2084-9869
ISSN:1233-9687
Journals System - logo
Scroll to top